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Introduction
Chemotaxis is a pivotal response of many cell types to external 
spatial cues. It plays important roles in diverse functions, such 
as fi  nding nutrients in prokaryotes, forming multicellular struc-
tures in protozoa, tracking bacterial infections in neutrophils, 
and organizing the embryonic cells in metazoa (Baggiolini, 
1998; Campbell and Butcher, 2000; Crone and Lee, 2002). 
In Dictyostelium discoideum cells, extracellular cAMP func-
tions as a chemoattractant that is detected by specifi  c G protein–
coupled surface receptors. Chemotaxis is achieved by coupling 
gradient sensing to basic cell movement. Two important questions 
on chemotaxis are (1) What is the compass detecting the cAMP 
gradient? and (2) How is this signal transduced to localized 
pseudopod formation?
Pseudopod extension at the leading edge is mediated by 
the formation of new actin fi  laments, whereas acto-myosin fi  la-
ments in the rear of the cell inhibit pseudopod formation and 
  retract the uropod. In D. discoideum, myosin fi  lament forma-
tion is regulated by cGMP (Bosgraaf and van Haastert, 2006), 
whereas in mammalian cells it is regulated by Rho-kinases 
(Xu et al., 2003). We are beginning to understand the signals 
that regulate actin polymerization at the front of the cell (Van 
Haastert and Devreotes, 2004; Affolter and Weijer, 2005; 
Franca-Koh et al., 2007). Phosphatidylinositol (3,4,5)-trisphosphate 
(PIP3) is a very strong candidate to mediate directional sensing 
in neutrophils and D. discoideum. PIP3 is formed at the side of 
the cell closest to the source of chemoattractant (Parent et al., 
1998; Hirsch et al., 2000; Servant et al., 2000; Funamoto et al., 
2002; Iijima and Devreotes, 2002). Furthermore, PIP3 is a very 
strong inducer of pseudopod extensions, as demonstrated in 
pten (phosphatase and tensin homologue)–null mutants with el-
evated PIP3 levels, and subsequently more pseudopods (Iijima 
and Devreotes, 2002). Unexpectedly, inhibition of PI3-kinase 
(PI3K) has only moderate effects on chemotaxis in D. discoideum 
(Funamoto et al., 2002; Iijima and Devreotes, 2002; Postma et al., 
2004b; Loovers et al., 2006) and mammalian cells (Wang et al., 
2002; Ward, 2004, 2006), demonstrating that PI3K signaling is 
dispensable for chemotaxis.
What are the signaling pathways that mediate chemotaxis 
in pi3k-null cells? It has been argued that the optimal second mes-
senger mediating directional sensing will have a lifetime of  5 s 
and a diffusion rate constant of  1 μm
2/s (Postma et al., 2004a). 
Molecules like cAMP, cGMP, H
+, K
+, or IP3 do not meet these 
criteria. PIP3, however, perfectly fi  ts in this biophysical profi  le: 
very low basal levels, rapid transient accumulation after cAMP 
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hemotaxis toward different cyclic adenosine mono-
phosphate (cAMP) concentrations was tested in 
Dictyostelium discoideum cell lines with deletion 
of speciﬁ  c genes together with drugs to inhibit one or all 
combinations of the second-messenger systems PI3-kinase, 
phospholipase C (PLC), phospholipase A2 (PLA2), and 
cytosolic Ca
2+. The results show that inhibition of either 
PI3-kinase or PLA2 inhibits chemotaxis in shallow cAMP 
gradients, whereas both enzymes must be inhibited to 
prevent chemotaxis in steep cAMP gradients, suggesting 
that PI3-kinase and PLA2 are two redundant mediators of 
chemotaxis. Mutant cells lacking PLC activity have normal 
chemotaxis; however, additional inhibition of PLA2 com-
pletely blocks chemotaxis, whereas inhibition of PI3-kinase 
has no effect, suggesting that all chemotaxis in plc-null 
cells is mediated by PLA2. Cells with deletion of the IP3 
receptor have the opposite phenotype: chemotaxis is com-
pletely dependent on PI3-kinase and insensitive to PLA2 
inhibitors. This suggest that PI3-kinase–mediated chemo-
taxis is regulated by PLC, probably through controlling 
PIP2 levels and phosphatase and tensin homologue (PTEN) 
activity, whereas chemotaxis mediated by PLA2 appears 
to be controlled by intracellular Ca
2+.
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stimulation with a half-life of  5 s, and a diffusion rate constant 
of  0.5 μm
2/s (Postma et al., 2004a). Possible alternatives for 
PIP3 in pi3k-null cells are the lipid products of PLC, PLA2, and 
PLD, or combinations of these enzymes. Ca
2+ may play a role 
in chemotaxis as well, because in cells its diffusion is rather 
slow (Tsaneva-Atanasova et al., 2005). In this study, we investi-
gated the role of several potential second-messenger systems in 
D. discoideum chemotaxis. The results show that inhibition of 
PI3K and PLA2 strongly reduces chemotaxis. Inhibition of PLC 
or intracellular Ca
2+ signaling has little direct effect on chemo-
taxis. However, chemotaxis in plc-null cells appears to be com-
pletely dependent on PLA2 activity, whereas chemotaxis in cells 
lacking the IP3 receptor depends only on PI3K activity, suggest-
ing that PLC and intracellular Ca
2+ are not mediators of chemo-
taxis but regulate the activity of PI3K and PLA2, respectively.
Results
The chemoattractant cAMP stimulates at least eight second-
messenger systems in D. discoideum, adenylyl cyclases, guanylyl 
cyclases, proton production, K
+ fluxes, Ca
2+ uptake and re-
lease from internal stores, PLC, PI3K, and PLA2. Null mutants 
of most second-messenger systems have been made; none of 
these mutants exhibit a severe chemotactic defect (Van Haastert 
and Devreotes, 2004; Affolter and Weijer, 2005). Apparently, 
multiple pathways mediate chemotaxis. To identify the signaling 
pathways that collectively mediate chemotaxis, we measured 
chemotaxis in several mutant cells treated with mixtures of 
drugs to inhibit one, multiple, or all messenger systems. To limit 
the number of combinations to be tested (all possible combina-
tions of 8 pathways is 8! or 40,320 conditions), as explained in 
the Introduction, we identifi  ed potential second messengers that 
have a diffusion rate constant between 0.3 and 3 μm
2/s and ac-
cumulate transiently with a lifetime of 3–10 s after stimulation 
with the chemoattractant cAMP. Potential second messengers 
are phospholipids such as PIP3 and phosphatidylinositol (4,5)-
bisphosphate (PIP2), fatty acids, and cytosolic Ca
2+. Therefore, 
we investigated four signaling pathways, PI3K, PLC, PLA2, 
and cytosolic Ca
2+.
For each second-messenger system, we aimed at collect-
ing two independent datasets, obtained either with a mutant de-
fective in that second-messenger system or with a drug inhibiting 
the enzyme activity, respectively. We have tested the following 
conditions: (1) pi3k-null or wild-type cells treated with the 
PI3K inhibitor LY294002 at a concentration of 50 μM, (2) plc-
null or wild-type cells treated with the PLC inhibitor U73122 at 
a concentration of 10 μM, (3) the PLA2 inhibitors quinacrine at 
20 μM and p-bromophenacyl bromide (BPB) at 2 μM, and (4) 
a combination of mutants and drugs to affect cytosolic Ca
2+, 
notably mutant cells lacking the IP3 receptor in combination 
with 10 mM EGTA to block Ca
2+ uptake. The concentrations of 
drugs used were obtained either from published dose response 
curves (U73122 [Seastone et al., 1999] and LY294002 [Loovers 
et al., 2006]) or from dose response curves presented in Fig. 1 
for BPB and quinacrine. Half-maximal inhibition of chemotaxis 
to 50 nM cAMP was observed at 0.5 μM BPB or 5 μM quina-
crine and >80% inhibition at a concentration of 2 μM BPB or 
50 μM quinacrine. Chemotaxis to 1,000 nM cAMP is only slightly 
inhibited, even at the highest concentrations used, indicating that 
BPB and quinacrine are not harmful to the cells. In addition, cells 
treated with BPB exhibit a normal PIP3 response, as shown by the 
translocation of PHcrac-GFP to the leading edge, suggesting that 
inhibition of the PLA2 pathway does not interfere with the PI3K 
pathway (see Fig. 5 D).
All single and multiple combinations inhibiting four sig-
naling pathways yielded  70 experimental conditions, to be 
tested at two cAMP concentrations with at least three replicates 
(Table S1, available at http://www.jcb.org/cgi/content/full/jcb
.200701134/DC1). We have used the small population assay 
(Konijn, 1970) to screen these 500 conditions. In this assay, 
small droplets containing wild-type or mutant cells are deposited 
on hydrophobic agar. Cells can freely move within the boundary 
of the droplet but cannot move out of the droplet. Therefore, any 
directional movement of the cells leads to the accumulation of 
cells at the boundary of the small population, which is rapidly 
scored. In the shallow absolute gradient induced by 50 nM cAMP 
(dC/dx = 100 pM/μm), a weak chemotaxis response is observed 
in  50–70% of the populations, whereas 1,000 nM cAMP 
induces a steep absolute gradient (dC/dx = 2,000 pM/μm) and 
a strong chemotaxis response in 90–100% of the populations. In 
videos that were analyzed for detailed cell movement, chemo-
taxis by 50 nM cAMP had the characteristics of a biased random 
walk with a chemotaxis index of  0.5, whereas the response to-
ward 1,000 nM cAMP exhibits the characteristics of directional 
movement with a chemotaxis index of  0.85. With this assay it 
is possible to simultaneously test, in 1 d, 30 different conditions 
(mutant cells or drugs) at two cAMP concentrations, each with 
12 populations that are observed at least four times. This large 
dataset is presented as Table S1. In Figs. 2 and 3, the results are 
discussed in a logical and reduced format.
PI3K and PLA2 are mediators 
of chemotaxis
The pi3k-null mutant has deletions of two genes encoding PI3K1 
and PI3K2 that, together, mediate essentially all cAMP-stimulated 
Figure 1.  Inhibition of chemotaxis by the PLA2 inhibitors BPB and quina-
crine and the PI3K inhibitor LY294002. Chemotaxis of wild-type cells 
was measured toward different concentrations of cAMP (A; with 50 μM 
LY294002, 20 μM quinacrine, and 2 μM BPB) at different concentrations 
of BPB, quinacrine, and LY294002 (B; with 50 and 1,000 nM cAMP). The 
results show strong inhibition at low cAMP concentrations but no inhibition 
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PIP3 formation (Huang et al., 2003). Fig. 2 A reveals that inhibi-
tion of PI3K activity, either with LY294002 or by disruption 
of pi3k, results in reduced chemotactic activity when measured 
with 50 nM cAMP, but inhibition of PI3K has no effect at 
1,000 nM cAMP. The 70% reduction of chemotaxis at 50 nM 
cAMP by LY294002 is substantially stronger that the 30% 
reduction seen in pi3k1/2-null cells. There are several potential 
explanations for this observation, such as the inhibition of the 
other PI3K3-5 by LY294002, the reduction of speed that is induced 
by LY294002 (Funamoto et al., 2002; Iijima and Devreotes, 
2002; Loovers et al., 2006), or up-regulation of the PLA2 path-
way in pi3k-null cells. The PLA2 inhibitors BPB and quinacrine 
have similar effects on chemotaxis as LY294002: partial inhibi-
tion at low cAMP concentrations but very little effect at high 
cAMP concentrations. When both PI3K and PLA2 enzyme 
  activities are inhibited, nearly all chemotactic activity at both 
cAMP concentrations is lost.
A different strategy to identify the collective second-
messenger systems for chemotaxis is presented in Fig. 2 B. First, 
all four second-messenger systems were blocked, by either a 
complete drug cocktail in wild-type cells (the PI3K inhibitor 
LY294002, the PLA2 inhibitors BPB or quinacrine, the PLC 
inhibitor U73122, and the Ca
2+ inhibitor EGTA) or limited 
drug cocktails in mutants lacking pi3k, plc, or the IP3 receptor 
gene iplA. In all these conditions, chemotaxis was completely 
blocked. Subsequently, one signaling pathway at a time was 
allowed to be active. The experiments reveal nearly normal 
chemotaxis when only PI3K or only PLA2 are active while the 
other three pathways are still inhibited (Fig. 2 B). The results of 
Fig. 2 indicate that PI3K or PLA2 alone can fully support chemo-
taxis and that both pathways must be inhibited to completely 
block chemotaxis.
The effect of inhibition of PI3K and PLA2 on chemo-
taxis was also investigated in an experimental setup where 
the cAMP gradient was created using micropipettes. Fig. 3 
presents the analysis of a video (Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200701134/DC1) in which 
cAMP-stimulated wild-type AX3 cells in buffer are treated 
sequentially with BPB and BPB + LY294002. The tracks 
of some representative cells are presented in Fig. 3 A, the 
chemotaxis index and speed of 30 cells for Video 1 in Fig. 
3 B, and the mean of several videos in Fig. 3 C. A pipette 
with cAMP induces a strong chemotaxis response in buffer. 
Upon addition of BPB, chemotaxis continues with nearly the 
same chemotaxis index at a reduced speed. Similar observa-
tions were made previously with LY294002 in the absence of 
BPB, showing nearly normal chemotaxis when only PI3K is 
inhibited (Funamoto et al., 2002; Iijima and Devreotes, 2002; 
Figure 2.  Role of PI3K, PLA2, PLC, and 
  cytosolic Ca
2+ in D. discoideum chemotaxis. 
Chemotaxis was measured in the absence or 
presence of 50 μM LY294002 (LY; PI3K inhibi-
tor), 10 μM U73122 (PLC inhibitor), 20 μM 
quinacrine (Quina) and 2 μM BPB (PLA2 inhib-
itors), and 10 mM EGTA to block Ca
2+ uptake. 
Four strains were used: wild-type (WT) AX3 
and the mutants pi3k-null, plc-null, and the IP3 
receptor–null  iplA
− lacking the IP3 receptor. 
Chemotaxis at 50 nM cAMP is a biased ran-
dom walk, whereas chemotaxis at 1,000 nM 
exhibits directional movement. (A) Experiments 
are presented with increasing complexity of 
inhibitors, to ﬁ  nd the second-messenger path-
ways that, together, are responsible for all 
chemotaxis. (B) Shown is a total mixture of in-
hibitors, leading to a complete blockade of 
chemotaxis, followed by decreasing complex-
ity of inhibitors, to ﬁ  nd the pathways that alone 
can induce chemotaxis. The results of A show 
that PI3K and PLA2 together are responsible 
for essentially all chemotaxis, and B shows that 
either the PI3K or the PLA2 pathway is sufﬁ  -
cient to provide full chemotactic activity. The 
PLC and Ca
2+ pathways apparently cannot 
mediate chemotaxis.JCB • VOLUME 177 • NUMBER 5 • 2007  812
Loovers et al., 2006; Fig. 3 C). However, upon addition of 
LY294002 to BPB-treated wild-type cells, chemotaxis toward 
the pipette is inhibited completely.
PLC and Ca
2+ are not mediators 
of chemotaxis
Inhibition of PLC activity by deletion of the unique plc gene or 
with the inhibitor U73122 has no effect on chemotaxis (Fig. 
2 A, bottom), consistent with previous experiments (Drayer et al., 
1994). Interference with the cytosolic Ca
2+ response, by either 
blocking Ca
2+ uptake with EGTA or IP3-mediated intracellular 
Ca
2+ release in cells lacking the IP3 receptor, also has no effect 
on chemotaxis at low or high cAMP concentrations. Fig. 2 B 
(bottom) presents the chemotactic data of conditions in which 
all pathways except PLC or Ca
2+ are active, revealing that PLC 
or Ca
2+ alone does not support chemotactic activity.
PLC and Ca
2+ are regulators of chemotaxis
Although PLC and Ca
2+ apparently cannot mediate chemotaxis, 
we have noticed that these second messengers appear to affect 
chemotaxis mediated by PI3K and PLA2. As shown above, che-
motaxis of wild-type cells is partly inhibited by the PI3K inhibitor 
LY294002 and partly by the PLA2 inhibitors BPB or quinacrine. 
In contrast, chemotaxis of plc-null cells is not inhibited at all by 
the PI3K inhibitor LY294002 and is completely inhibited by the 
PLA2 inhibitor BPB (Fig. 4). This suggests that in plc-null cells, 
chemotaxis is mediated largely by PLA2 and not by PI3K. The 
mutant with a deletion of the IP3 receptor has the opposite pheno-
type. Chemotaxis is indistinguishable from chemotaxis of wild 
type, as presented previously (Traynor et al., 2000), but now chemo-
taxis is completely blocked by the PI3K inhibitor LY294002, 
whereas the PLA2 inhibitors have no effect, suggesting that in IP3 
receptor–null cells, all chemotaxis is mediated by PI3K and not 
by PLA2. As shown in Fig. 2, inhibition of PLC activity or inhibi-
tion of Ca
2+ response has little   effect on chemotaxis. However, 
blockade of both PLC and all Ca
2+ responses (IP3 receptor null in 
EGTA treated with U73122) yield a very strong inhibition of chemo-
taxis at 50 and 1,000 nM cAMP, consistent with the prediction 
that, at this condition, both PI3K and PLA2 are inhibited.
Reduced PIP3 response in plc-null cells
The notion that in plc-null cells all chemotaxis is apparently 
mediated by PLA2 and not by PI3K could imply that PI3K is 
not activated by cAMP in plc-null cells. To test this hypothesis, 
we transformed plc-null cells with the PIP3 sensor PHcrac-GFP 
and stimulated the cells with cAMP. Wild-type cells that che-
motax toward a pipette releasing cAMP exhibit a crescent of 
PHcrac-GFP at the leading edge (Parent et al., 1998). Such a 
crescent is still present in wild-type cells treated with the PLA2 
inhibitor BPB but absent in wild-type cells treated with the 
PI3K inhibitor LY294002 (Fig. 5, C and D). Although plc-null 
cells exhibit very good chemotaxis toward a pipette with cAMP, 
PHcrac-GFP hardly localizes at the leading edge and remains 
cytosolic, as in unstimulated cells (Fig. 5 B). We conclude that 
plc-null cells show an impaired activation of the PI3K pathway, 
which explains why the PI3K inhibitor LY294002 has no effect 
on chemotaxis of plc-null cells and the PLA2 inhibitors show 
such a strong effect.
Discussion
Toward a model for chemotaxis 
in D. discoideum
The experiments reveal that PI3K and PLA2 signaling together 
are responsible for nearly all chemotaxis in shallow and steep 
cAMP gradients (Fig. 6). In steep cAMP gradients, both PI3K 
and PLA2 signaling must be inhibited to observe a reduction of 
chemotactic activity. However, in shallow gradients, inhibition 
of either one pathway already leads to a strong inhibition of 
Figure 3.  Chemotaxis of wild-type AX3 cells measured with micro  pipettes. 
A micropipette releasing cAMP is positioned in a ﬁ  eld of cells at t = 0; at 
t = 4 min, 5 μM BPB is added, and at t = 12 min, 50 μM LY294002 is 
added. Images were captured every 10 s (presented as Video 1, available 
at http://www.jcb.org/cgi/content/full/jcb.200701134/DC1). (A) The 
tracks of 11 cells are shown for chemotaxis to a pipette with cAMP (asterisk) 
in buffer (black lines; t = 0–4 min) in BPB (green lines; t = 4–12 min) 
and LY294002 + BPB (red lines; t = 12–26 min). Bar, 100 μm. (B) The 
ﬁ  gure shows the chemotaxis index (closed circle) and speed (open circle) 
as means and SEM of  30 cells. (C) The chemotaxis index (black bars) 
and speed (gray bars) of wild-type cells was determined in the absence or 
presence of 5 μM BPB and/or 50 μM LY294002. The data shown are the 
means and SEM of the chemotaxis index and speed from three independent 
experiments, each with  30 cells, determined from 5 min after addition of 
the inhibitors.CHEMOTAXIS BY PI3K AND PLA2 • VAN HAASTERT ET AL. 813
chemotaxis. Cell movement in buffer is best described as a random 
walk, i.e., every 30–60 s, cells extend a new pseudopod in a ran-
dom direction. In shallow gradients, chemotaxis is essentially a 
biased random walk, i.e., new pseudopodia are still extended in 
all directions, but more frequently in the direction of the gradient 
than in other directions. We suppose that the time and place 
where a new pseudopod is made is regulated by activators and 
inhibitors and that stimulation of the cAMP receptor will infl  u-
ence the activity of one or multiple of these activators and in-
hibitors, thereby affecting pseudopod formation. In a shallow 
gradient, where the probability that a pseudopod is extended in 
the direction of the gradient is low, interference with any of these 
hypothetical activators or inhibitors will lead to a reduction of 
chemotaxis. The observation that in a shallow cAMP gradient, 
inhibition of either PI3K or PLA2 signaling inhibits chemotaxis 
suggests that downstream components of both pathways infl  u-
ence the probability of making a new pseudopod. In steeper 
  gradients, nearly all pseudopodia are extended in the direction 
of the gradient, and interference with one of the hypothetical 
activators or inhibitors will have little effect as long as other 
activators or inhibitors remain functional. Thus, the PI3K and 
PLA2 pathways are both required for good chemotaxis in 
shallow gradients but are redundant in steep gradients.
The formation of second messengers at a specifi  c place 
regulates the local formation of a pseudopod. These second 
messengers are presumably PIP3 for the PI3K pathway, but 
there could be several second messengers for the PLA2 path-
way. The PLA2-catalyzed hydrolysis of membrane phospho-
lipids results in the stoichiometric production of a free fatty acid 
and a lysophospholipid. Both of these phospholipid metabolites 
may serve as potential second messengers. Recently, the fi  rst 
results of a genetic screen for LY294002-supersensitive chemo-
taxis mutants were reported (Chen et al., 2007). A gene was 
identifi  ed that belongs to the Ca
2+-independent PLA2 (iPLA2, 
group VI PLA2) class, whose inactivation in a wild-type back-
ground had no effect, but inactivation in a pi3k-null background 
nearly completely inhibited chemotaxis, which is in excellent 
agreement with the present observations. The regulation of this 
PLA2 by upstream components requires further investigation, 
as well as the identifi  cation of the messenger molecules of this 
PLA2 pathway that regulate pseudopod formation.
We routinely record chemotaxis data at a distance of 50–
100 μm from the pipette, where that gradient is  500–2,000 
pM/μm. It should be mentioned that very close to the pipette, 
wild-type cells in LY294002 + BPB or pi3k-null cells in BPB 
exhibit a small but signifi  cant chemotaxis response (P < 0.01); 
the response was observed within 30 μm from the tip, where the 
gradient is very steep, at >12,500 pM/μm. This residual re-
sponse close to the pipette is consistent with the small residual 
response in the small population assay in steep gradients toward 
1,000 nM cAMP. We also observed that this residual response in 
LY294002 + BPB was somewhat stronger when cells are 
starved and pulsed with cAMP for 7, instead of 5, h. Several non-
exclusive models may explain these observations, including re-
sidual PI3K and PLA2 activity resulting from partial inhibition of 
these enzymes, reduced uptake of the inhibitors in longer starved 
cells, or the presence of another signaling pathway that is active 
in very steep gradients or in cells starved for a longer period.
PLC and intracellular Ca
2+ participate in chemotaxis, 
most likely not as mediators, but as regulators of PI3K and 
PLA2, respectively. Inhibition of the PLC and Ca
2+ pathways in 
control cells has no effect on chemotaxis. However, signifi  cant 
chemotactic defects are observed when PLC or Ca
2+ is inhib-
ited in a background with inhibited PI3K or PLA2 (P < 0.01). 
The cAMP-mediated PIP3 response is nearly absent in plc-null 
cells, and inhibitors suggest that chemotaxis in plc-null cells is 
exclusively mediated by PLA2. The mechanism by which plc-null 
Figure 4.  PLC and Ca
2+ are regulators of 
chemotaxis. Chemotaxis was measured with 
the strains indicated in the absence or presence 
of the indicated inhibitors. The results show 
that inhibition of PLC or PLC and PI3K has little 
effect on chemotaxis, whereas inhibition of PLC 
and PLA2 completely blocks chemotaxis, sug-
gesting that in plc-null cells, all chemotaxis is 
mediated by PLA2. Conversely, in IP3 receptor–
null cells, all chemotaxis is dependent on PI3K. 
Inhibition of both PLC and Ca
2+ uptake and 
release in IP3 receptor–null cells in EGTA and 
U73122 leads to complete inhibition of chemo-
taxis at both 50 and 1,000 nM cAMP. WT, 
wild type.
Figure 5.  Reduced PIP3 formation in plc-null cells. Wild-type cells (A, C, 
and D) and plc-null cells (B) expressing the PIP3 sensor PHcrac-GFP were 
stimulated with a micropipette releasing a gradient of cAMP. Wild-type 
cells were incubated in buffer (A), 50 μM LY294002 (C), or 5 μM BPB (D). 
The results show a strongly diminished PIP3 response in plc-null cells and 
wild-type cells treated with the PI3K inhibitor LY294002, but normal PIP3 
response of wild-type cells in buffer or treated with the PLA2 inhibitor BPB. 
The asterisks indicate the position of the pipette. Bar, 10 μm.JCB • VOLUME 177 • NUMBER 5 • 2007  814
cells have reduced PIP3 levels is intriguing; plc-null cells have 
elevated PIP2 levels (Drayer et al., 1994), i.e., more substrate for 
PI3K, which would predict increased PIP3 levels, but we ob-
served the opposite. It is known that the PIP3-degrading enzyme 
PTEN binds to PIP2, which is essential for its catalytic activity 
(Iijima et al., 2004), suggesting that the enhanced PIP2 levels in 
plc-null cells trap PTEN at the membrane, preventing the 
 accumulation of PIP3. In accordance with this hypothesis, we 
observed that the level of membrane-associated PTEN-GFP is 
higher in plc-null cells than in wild-type cells (unpublished 
results), suggesting that the reduced PIP3 level in plc-null cells 
is caused by enhanced activity of PTEN.
In D. discoideum, three pathways contribute to an eleva-
tion of cytosolic Ca
2+ levels: (1) uptake of Ca
2+ from the extra-
cellular medium, (2) the IP3 receptor–mediated release of Ca
2+ 
from the endoplasmic reticulum, and (3) the fatty acid–mediated 
release of Ca
2+ from acidosomes. The IP3-mediated release of 
Ca
2+ from internal stores cannot be inhibited by deleting the 
single plc gene, because in D. discoideum, IP3 is also produced 
by degradation of IP5, a pathway that is up-regulated in plc-null 
cells (Drayer et al., 1994; van Dijken et al., 1995). However, IP3-
mediated Ca
2+ release can be effectively blocked by deletion of 
the IP3 receptor in iplA-null cells (Traynor et al., 2000). Simulta-
neous inhibition of Ca
2+ uptake and Ca
2+ release pathways in 
iplA-null cells has little effect, but now chemotaxis is insensitive 
to PLA2 inhibitors and completely blocked by LY294002, indi-
cating that chemotaxis is only mediated by the PI3K pathway. 
Apparently, the PLA2 pathway requires a rise in intracellular 
Ca
2+, which could be a direct effect of Ca
2+ on the enzyme, as 
many PLA2 enzymes are Ca
2+ dependent (Chakraborti, 2003).
In summary, we propose that chemotaxis at the leading 
edge of D. discoideum cells is mediated predominantly by two 
pathways, PI3K and PLA2 (Fig. 6). Each of these two pathways 
is regulated by another cAMP-stimulated pathway that, by it-
self, has no direct effect on chemotaxis. The PI3K pathway is 
regulated through PIP2/PTEN by the PLC pathway. The PLA2 
pathway depends on cytosolic Ca
2+, which is regulated by IP3 
(and thus partly by PLC), fatty acids (and thus partly by PLA2), 
and Ca
2+ uptake. These intertwined and partly redundant sig-
naling cascades make chemotaxis in D. discoideum very robust 
because multiple signaling pathways must be deleted to obtain 
a strong reduction of chemotaxis.
The model for chemotactic signaling may help focus ex-
periments for further understanding the molecular mechanism 
of chemotaxis. It could be argued that the PI3K pathway is dis-
pensable for chemotaxis and that PIP3 is not required for 
chemotaxis. However, in wild-type cells, PIP3 is formed at the 
leading edge in a cAMP gradient, and PIP3 has pronounced ef-
fects on the time and place of pseudopod formation, suggesting 
that in wild-type cells, pseudopodia are always extended at 
places with elevated PIP3 levels. Experiments investigating the 
role of PIP3 in chemotaxis can be designed better now that we 
know that in PLA2-inhibited cells, chemotaxis fully depends on 
PI3K signaling. The same arguments can be used for the PLA2 
pathway: it is dispensable for chemotaxis but functional in wild-
type cells and can be investigated more specifi  cally in pi3k-null 
cells. The notion that D. discoideum cells exhibit very good 
chemotaxis when either the PI3K or PLA2 pathway is inhibited 
implies that these pathways are not essential components of 
the cells’ compass, suggesting that the compass is upstream of 
PI3K and PLA2. The compass might be identifi  ed by searching 
for molecules that are localized toward the pipette in cells with 
complete inhibition of PI3K and PLA2 signaling, and therefore 
also of all downstream components. The notion that all chemo-
taxis in D. discoideum is mediated by either PI3K or by PLA2 
signaling provides a strong focus to unravel the obviously com-
plex signaling cascades to actin polymerization and pseudopod 
formation at the leading edge in D. discoideum.
Materials and methods
Strains and growth conditions
The D. discoideum strain AX3 was used as wild-type control in all experi-
ments. The mutants strains used are the plc-null strain 1.19 (Drayer et al., 
1995), the pi3k-null pi3k1
−/pi3k2
− strain GMP1 (Funamoto et al., 2001), 
and the iplA-null strain HM1038, lacking the IP3 receptor (Traynor et al., 
2000). Cells were grown in shaking culture in HG5 medium (contains, per 
liter, 14.3 g oxoid peptone, 7.15 g bacto yeast extract, 1.36 g Na2HPO4 × 
12 H2O, 0.49 g KH2PO4, and 10.0 g glucose) at a density between 
5 × 10
5 and 6 × 10
6 cells/ml. Cells were harvested by centrifugation for 
3 min at 300 g, washed in PB (10 mM KH2PO4/Na2HPO4, pH 6.5), and 
starved in PB in 6-well plates (Nunc) for 5 h. Cells were then resuspended 
in PB, centrifuged, washed once in PB, and resuspended in PB at a density 
of 6 × 10
6 cells/ml.
Chemotaxis
Chemotaxis measured with the small population assay (Konijn, 1970) was 
performed in the wells of a 6-well plate with 1 ml agar nonnutrient hydro-
phobic agar (11 mM KH2PO4, 2.8 mM Na2HPO4, and 7 g/liter hydro-
phobic agar) containing the indicated concentration of the drugs. Droplets of 
 0.1 μl of 5 h–starved cells (6 × 10
6 cells/ml) were placed on the agar. 
After 30 min, chemotaxis toward cAMP was tested by placing a second 
Figure 6.  Model of signaling cascades leading to D. discoideum chemo-
taxis. cAMP activates multiple pathways. The PI3K and PLA2 pathway are 
parallel mediators of chemotaxis: either one can mediate chemotaxis, and 
chemotaxis is blocked nearly completely when both pathways are inhib-
ited. PIP3 is the likely mediator of the PI3K pathway, by recruiting PH-
  containing proteins modulating the actin cytoskeleton. The messenger of 
the PLA2 pathway controlling chemotaxis is unknown. The PI3K pathway 
appears to be controlled by the PLC pathway, presumably at the level of 
PIP2 degradation, leading to a reduction of membrane-associated PTEN 
that degrades PIP3. The PLA2 pathway is dependent on cytosolic Ca
2+, but 
it is unknown whether this occurs at the level of PLA2 activation or the   action 
of downstream messengers on the chemotaxis system. Cytosolic Ca
2+ is 
regulated by Ca
2+ uptake from the medium (which is both G protein de-
pendent and independent), free fatty acid (FFA)–mediated Ca
2+ release 
from acidic stores, and the IP3 receptor–mediated Ca
2+ release from the 
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0.1 μl droplet, with the indicated concentration of cAMP, next to the drop-
let of cells. The distribution of the cells in the droplet was observed about 
every 10 min for 90 min. Chemotaxis of cells within a droplet was scored 
positive when the cell density at the cAMP side was at least twice as high 
as the opposite side of the droplet (Konijn, 1970). The maximal chemo-
tactic response is faster for 50 nM cAMP (20–40 min) than for 1,000 nM 
cAMP (40–60 min). Also, some mutants respond faster (plc-null) or slower 
(pi3k-null) than wild-type cells. Recorded is the fraction of droplets scored 
positive, averaged over three successive observations at and around the 
moment of the maximal response. The data presented are the means and 
SEMs of at least three independent measurements on different days. Chemo-
taxis was also measured with micropipettes containing 100 μM cAMP 
using an inverted light microscope (CK40; Olympus) with a 20× NA 0.4 
objective (LWD A240; Olympus) equipped with a charge-coupled device 
camera (TK-C1381; JVC). The ﬁ  eld of observation is 358 × 269 μm. 
Images were captured every 10 s for 30 min on a PC using VirtualDub 
software and Indeo Video 5.10 (Ligos) compression. The chemotaxis index, 
deﬁ  ned as the ratio of the cell displacement in the direction of the gradient 
and its total traveled distance, was determined for  25 cells in a video as 
follows. First, the position of the centroid of a cell was determined with 
ImageJ (rsb.info.nih.gov/ij) for frames at 60-s intervals, yielding a series of 
coordinates for that cell. Using these coordinates, the chemotaxis index of 
each 60-s step was calculated and averaged, yielding the chemotaxis 
index for that cell in the video. The data shown are the mean and SEM of 
the chemotaxis indices from at least three independent experiments with 
 25 cells per experiment.
The same experimental setup with micropipettes was used for analy-
ses of cells expressing the PIP3 sensor PHcrac-GFP. Confocal images 
were recorded with a confocal laser-scanning microscope (LSM 510 META-
NLO; Carl Zeiss MicroImaging, Inc.) equipped with a plan-apochromatic 
63× NA 1.4 objective (Carl Zeiss MicroImaging, Inc.). For excitation of 
the ﬂ   uorochrome GFP (S65T variant) a 488-nm argon/krypton laser 
was used, and the ﬂ  uorescence was ﬁ  ltered through BP500-530 and IR 
LP560 and detected by a photomultiplier tube. The ﬁ  eld of observation was 
206 × 206 μm.
Gradients of cAMP during chemotavxis
In the small population assay, the applied cAMP diffuses in the agar, lead-
ing to a transient cAMP gradient at the cells. The maximal cAMP concen-
tration C(x) and the absolute spatial gradient  () Cx Ñ  are described as
 
() ()
33
3 4 0.48  and  2.42 , dd
rr
Cx C Cx C
x x
=Ñ =
 
where r is the radius of the cAMP droplet (150 μm), x is the distance be-
tween cell population and cAMP source (250 μm), and Cd is the applied 
cAMP concentration in the droplet. The absolute cAMP gradients at 50 and 
1,000 nM cAMP are  100 and 2,000 pM/μm, respectively.
When a pipette ﬁ  lled with cAMP is inserted in a ﬁ  eld of D. discoi-
deum cells, cAMP will diffuse continuously from the pipette, leading within 
1 min to a stable spatial gradient. The concentration C(x) and the spatial 
gradient  () Cx Ñ  are dependent on the distance (x) from the pipette 
  according to
 
() ()
2 / a n d   / , pp Cx C x Cx C x =a Ñ =- a
 
where Cp is the cAMP concentration in the pipette and α is a proportional-
ity constant that depends on the geometry of the pipette and the applied 
pressure. The formation of the cAMP gradient was deduced by measuring 
the release of the ﬂ  uorescent dye Lucifer yellow (mol wt = 457 D) from the 
pipette with the confocal ﬂ  uorescent microscope and calibrated using the 
ﬂ  uorescence intensity of diluted Lucifer yellow added homogeneously to 
the bath. The experiments yield α = 0.05 and demonstrate that the equa-
tions are accurate descriptions of the cAMP gradient at a distance >15 μm 
from the pipette; at shorter distances, more complex equations are re-
quired. At 100, 50, and 20 μm from the pipette, the absolute cAMP gradi-
ent is 500, 2,000, and 12,500 pM/μm, respectively.
Online supplemental material
Table S1 presents the chemotaxis data obtained with the small population 
assay of  70 conditions with different combinations of cell strains and in-
hibitors. Video 1 shows chemotaxis of wild-type AX3 cells toward a pipette 
with cAMP in buffer. The PLA2 inhibitor BPB is added at 4 min, and the 
PI3K inhibitor LY294002 is added at 12 min. Video 2 shows the localization 
of PHcrac-GFP (detecting PIP3) at the leading edge of wild-type cells chemo-
taxing toward cAMP. Video 3 shows plc-null cell movement toward a pipette 
with cAMP. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200701134/DC1.
The mutant strains used in this study were obtained from the Dictyostelium 
stock center.
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